Vila M, Agusti A, Vestbo J, Celli B, Cosio B, Silverman E
ERJ Open Res. 2025; 11(1).
PMID: 40008176
PMC: 11849125.
DOI: 10.1183/23120541.00671-2024.
Wang J, Yu L, Yang Z, Shen P, Sun Y, Shui L
Int J Epidemiol. 2025; 54(2).
PMID: 39993264
PMC: 11849956.
DOI: 10.1093/ije/dyae174.
Li H, Ma Y, Li T, Zeng Z, Luo L, Liu X
Tob Induc Dis. 2024; 22.
PMID: 38650847
PMC: 11033979.
DOI: 10.18332/tid/186183.
Yang M, Liu Y, Zhao Y, Wang Z, He J, Wang Y
Int J Chron Obstruct Pulmon Dis. 2024; 19:907-919.
PMID: 38628984
PMC: 11020290.
DOI: 10.2147/COPD.S444580.
Nkhoma K, Farrant L, Mzimkulu O, Hunter J, Higginson I, Gao W
Int J Chron Obstruct Pulmon Dis. 2023; 18:1665-1679.
PMID: 37554921
PMC: 10404593.
DOI: 10.2147/COPD.S395834.
Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway.
Song Y, Fu W, Zhang Y, Huang D, Wu J, Tong S
Respir Res. 2023; 24(1):69.
PMID: 36879222
PMC: 9990325.
DOI: 10.1186/s12931-023-02375-9.
Fractional Dynamics Foster Deep Learning of COPD Stage Prediction.
Yin C, Udrescu M, Gupta G, Cheng M, Lihu A, Udrescu L
Adv Sci (Weinh). 2023; 10(12):e2203485.
PMID: 36808826
PMC: 10131808.
DOI: 10.1002/advs.202203485.
Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD.
Hanlon P, Guo X, McGhee E, Lewsey J, McAllister D, Mair F
NPJ Prim Care Respir Med. 2023; 33(1):1.
PMID: 36604427
PMC: 9816100.
DOI: 10.1038/s41533-022-00324-5.
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank.
Hanlon P, Lewsey J, Quint J, Jani B, Nicholl B, McAllister D
BMJ Open Respir Res. 2022; 9(1).
PMID: 35787523
PMC: 9255399.
DOI: 10.1136/bmjresp-2022-001314.
Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan.
Agusti A, Melen E, DeMeo D, Breyer-Kohansal R, Faner R
Lancet Respir Med. 2022; 10(5):512-524.
PMID: 35427533
PMC: 11428195.
DOI: 10.1016/S2213-2600(21)00555-5.
Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries.
Zeng L, Hussain M, Syed S, Saadullah M, Jamil Q, Alqahtani A
Front Public Health. 2022; 9:757089.
PMID: 35265582
PMC: 8899038.
DOI: 10.3389/fpubh.2021.757089.
Substance Use and Misuse among Adults with Chronic Obstructive Pulmonary Disease in the United States, 2015-2019: Prevalence, Association, and Moderation.
Alanazi A, Alqahtani M, Alquaimi M, Alotaibi T, Algarni S, Ismaeil T
Int J Environ Res Public Health. 2022; 19(1).
PMID: 35010669
PMC: 8744618.
DOI: 10.3390/ijerph19010408.
Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health Study.
Bui D, Agusti A, Walters H, Lodge C, Perret J, Lowe A
ERJ Open Res. 2021; 7(3).
PMID: 34527727
PMC: 8435806.
DOI: 10.1183/23120541.00020-2021.
Common Mental Disorders, Functional Limitation and Diet Quality Trends and Related Factors among COPD Patients in Spain, 2006-2017: Evidence from Spanish National Health Surveys.
Portero de la Cruz S, Cebrino J
J Clin Med. 2021; 10(11).
PMID: 34070391
PMC: 8197509.
DOI: 10.3390/jcm10112291.
Macrophages Inhibit Ciliary Protein Levels by Secreting BMP-2 Leading to Airway Epithelial Remodeling Under Cigarette Smoke Exposure.
Wang Z, Liang W, Ma C, Wang J, Gao X, Wei L
Front Mol Biosci. 2021; 8:663987.
PMID: 33981724
PMC: 8107431.
DOI: 10.3389/fmolb.2021.663987.
Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease.
Yang Y, Jin X, Jiao X, Li J, Liang L, Ma Y
Evid Based Complement Alternat Med. 2021; 2020:8871105.
PMID: 33488753
PMC: 7790571.
DOI: 10.1155/2020/8871105.
Phenotypic characterisation of early COPD: a prospective case-control study.
Cosio B, Pascual-Guardia S, Borras-Santos A, Peces-Barba G, Santos S, Vigil L
ERJ Open Res. 2020; 6(4).
PMID: 33043045
PMC: 7533304.
DOI: 10.1183/23120541.00047-2020.
Challenges to the Application of Integrated, Personalized Care for Patients with COPD-A Vision for the Role of Clinical Information.
Vanfleteren L, van t Hul A, Kulbacka-Ortiz K, Andersson A, Ullman A, Ingvar M
J Clin Med. 2020; 9(5).
PMID: 32370150
PMC: 7290491.
DOI: 10.3390/jcm9051311.
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document.
Bouza E, Alvar A, Almagro P, Alonso T, Ancochea J, Barbe F
Rev Esp Quimioter. 2020; 33(1):49-67.
PMID: 31933347
PMC: 6987629.
DOI: 10.37201/req/2064.2019.
Chronic obstructive pulmonary disease at the beginning of the XXI Century.
Agusti A, Zhang J
J Thorac Dis. 2020; 11(11):E210-E213.
PMID: 31903284
PMC: 6940226.
DOI: 10.21037/jtd.2019.10.50.
